BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 37470668)

  • 21. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
    Neftel C; Laffy J; Filbin MG; Hara T; Shore ME; Rahme GJ; Richman AR; Silverbush D; Shaw ML; Hebert CM; Dewitt J; Gritsch S; Perez EM; Gonzalez Castro LN; Lan X; Druck N; Rodman C; Dionne D; Kaplan A; Bertalan MS; Small J; Pelton K; Becker S; Bonal D; Nguyen QD; Servis RL; Fung JM; Mylvaganam R; Mayr L; Gojo J; Haberler C; Geyeregger R; Czech T; Slavc I; Nahed BV; Curry WT; Carter BS; Wakimoto H; Brastianos PK; Batchelor TT; Stemmer-Rachamimov A; Martinez-Lage M; Frosch MP; Stamenkovic I; Riggi N; Rheinbay E; Monje M; Rozenblatt-Rosen O; Cahill DP; Patel AP; Hunter T; Verma IM; Ligon KL; Louis DN; Regev A; Bernstein BE; Tirosh I; Suvà ML
    Cell; 2019 Aug; 178(4):835-849.e21. PubMed ID: 31327527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.
    Dravis C; Chung CY; Lytle NK; Herrera-Valdez J; Luna G; Trejo CL; Reya T; Wahl GM
    Cancer Cell; 2018 Sep; 34(3):466-482.e6. PubMed ID: 30174241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
    Berger A; Brady NJ; Bareja R; Robinson B; Conteduca V; Augello MA; Puca L; Ahmed A; Dardenne E; Lu X; Hwang I; Bagadion AM; Sboner A; Elemento O; Paik J; Yu J; Barbieri CE; Dephoure N; Beltran H; Rickman DS
    J Clin Invest; 2019 Jul; 129(9):3924-3940. PubMed ID: 31260412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response.
    Johnson KC; Anderson KJ; Courtois ET; Gujar AD; Barthel FP; Varn FS; Luo D; Seignon M; Yi E; Kim H; Estecio MRH; Zhao D; Tang M; Navin NE; Maurya R; Ngan CY; Verburg N; de Witt Hamer PC; Bulsara K; Samuels ML; Das S; Robson P; Verhaak RGW
    Nat Genet; 2021 Oct; 53(10):1456-1468. PubMed ID: 34594038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
    Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
    Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetics as a mediator of plasticity in cancer.
    Feinberg AP; Levchenko A
    Science; 2023 Feb; 379(6632):eaaw3835. PubMed ID: 36758093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular principles of metastasis: a hallmark of cancer revisited.
    Fares J; Fares MY; Khachfe HH; Salhab HA; Fares Y
    Signal Transduct Target Ther; 2020 Mar; 5(1):28. PubMed ID: 32296047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexity in cancer stem cells and tumor evolution: Toward precision medicine.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2017 Jun; 44():3-9. PubMed ID: 28254567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.
    Sfakianos JP; Daza J; Hu Y; Anastos H; Bryant G; Bareja R; Badani KK; Galsky MD; Elemento O; Faltas BM; Mulholland DJ
    Nat Commun; 2020 May; 11(1):2540. PubMed ID: 32439865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.
    Xu Y; Wang Z; Sjöström M; Deng S; Wang C; Johnson NA; Gonzalez J; Li X; Metang LA; Tirado CR; Mukherji A; Wainwright G; Yu X; Yang Y; Barnes S; Hofstad M; Zhu H; Hanker A; He HH; Chen Y; Wang Z; Raj G; Arteaga C; Feng F; Wang Y; Wang T; Mu P
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
    Zhang J; Huang L; Ge G; Hu K
    Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity.
    Fagnocchi L; Poli V; Zippo A
    Cell Mol Life Sci; 2018 Jul; 75(14):2537-2555. PubMed ID: 29691590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.
    Kukkonen K; Taavitsainen S; Huhtala L; Uusi-Makela J; Granberg KJ; Nykter M; Urbanucci A
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming to developmental plasticity in cancer stem cells.
    O'Brien-Ball C; Biddle A
    Dev Biol; 2017 Oct; 430(2):266-274. PubMed ID: 28774727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules.
    Dhaliwal A; Pelka S; Gray DS; Moghe PV
    Sci Rep; 2018 Nov; 8(1):16289. PubMed ID: 30389989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.
    Garcia-Gomez A; Rodríguez-Ubreva J; Ballestar E
    Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Melocchi V; Dama E; Mazzarelli F; Cuttano R; Colangelo T; Di Candia L; Lugli E; Veronesi G; Pelosi G; Ferretti GM; Taurchini M; Graziano P; Bianchi F
    Oncogene; 2021 Aug; 40(31):4980-4991. PubMed ID: 34172935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.
    Singh N; Ramnarine VR; Song JH; Pandey R; Padi SKR; Nouri M; Olive V; Kobelev M; Okumura K; McCarthy D; Hanna MM; Mukherjee P; Sun B; Lee BR; Parker JB; Chakravarti D; Warfel NA; Zhou M; Bearss JJ; Gibb EA; Alshalalfa M; Karnes RJ; Small EJ; Aggarwal R; Feng F; Wang Y; Buttyan R; Zoubeidi A; Rubin M; Gleave M; Slack FJ; Davicioni E; Beltran H; Collins C; Kraft AS
    Nat Commun; 2021 Dec; 12(1):7349. PubMed ID: 34934057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-genetic mechanisms of therapeutic resistance in cancer.
    Marine JC; Dawson SJ; Dawson MA
    Nat Rev Cancer; 2020 Dec; 20(12):743-756. PubMed ID: 33033407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cancer epigenome: Non-cell autonomous player in tumor immunity.
    Kato S; Maeda Y; Sugiyama D; Watanabe K; Nishikawa H; Hinohara K
    Cancer Sci; 2023 Mar; 114(3):730-740. PubMed ID: 36468774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.